Page last updated: 2024-08-21

carvacrol and Angiogenesis, Pathologic

carvacrol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bajpai, VK; Bhardwaj, M; Huh, YS; Kang, SC; Khan, I; Lee, H; Oh, MH; Shukla, S	1

Other Studies

1 other study(ies) available for carvacrol and Angiogenesis, Pathologic

Article	Year
Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model. Colloids and surfaces. B, Biointerfaces, 2019, Sep-01, Volume: 181 Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cell Proliferation; Cyclooxygenase 2; Cymenes; Down-Regulation; Drug Carriers; Drug Screening Assays, Antitumor; Emulsions; Humans; Lung Neoplasms; Mice; Nanoparticles; Neoplasms, Experimental; Neovascularization, Pathologic; Particle Size; Platelet Endothelial Cell Adhesion Molecule-1; Surface Properties; Tumor Cells, Cultured; Vascular Endothelial Growth Factors	2019

Article

Year

Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model.

Colloids and surfaces. B, Biointerfaces, 2019, Sep-01, Volume: 181

Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cell Proliferation; Cyclooxygenase 2; Cymenes; Down-Regulation; Drug Carriers; Drug Screening Assays, Antitumor; Emulsions; Humans; Lung Neoplasms; Mice; Nanoparticles; Neoplasms, Experimental; Neovascularization, Pathologic; Particle Size; Platelet Endothelial Cell Adhesion Molecule-1; Surface Properties; Tumor Cells, Cultured; Vascular Endothelial Growth Factors

2019